drugset
Drugs / Sanofi-Pasteur IPV
last change Dec 2014 re-read 3 minutes ago

Sanofi-Pasteur IPV

Vaccine

Developed for
poliomyelitis
Investigated by
Bill and Melinda Gates Foundation · Centers for Disease Control and Prevention · Fidec Corporation

Trials 1

today NCT01831050 · Ph 4
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01831050 May 2013 → Apr 2014 poliomyelitis Fidec Corporation Completed Met primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Sanofi-Pasteur IPV ClinicalTrials.gov intervention name — accepted as the source's own label NCT01831050 ↗
Modality Vaccine “Inactivated poliovirus vaccine is produced by Sanofi-Pasteur” NCT01831050 ↗